Modification to the A11 HERV-E TCR and T cell product to improve the therapeutic efficacy for ccRCC patients.
Closed Pre-Solicitation Posted
- Solicitation number
- 75N98026Q00392
- Agency
-
Office of Logisitics and Acquisition Operations
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 622110 General Medical and Surgical Hospitals
- PSC
- R499 Support- Professional: Other
- Place of performance
- Bethesda, Maryland 20892, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institutes of Health, Office of the Director, intends to award a non-competitive contract to Loyola University of Chicago for modification and optimization of the A11 HERV-E TCR and T cell product to improve therapeutic efficacy for clear cell renal cell carcinoma patients, with capability statements due June 3, 2026 at 9:00 AM Eastern time. The Government reserves the right to proceed on a competitive basis.
This sole-source procurement is structured under FAR Part 13 Simplified Acquisition Procedures, with a contract ceiling not exceeding $350,000. Loyola University of Chicago is identified as the sole source possessing the unique combination of scientific expertise, proprietary knowledge, prior developmental experience, and access to specific reagents, cell lines, vector constructs, and manufacturing methodologies required for this highly specialized research. The work builds upon previous Phase I clinical trials conducted at the NIH Clinical Center and requires continued optimization of the TCR construct and manufacturing process.
Interested parties must submit capability statements, technical proposals, cost-price proposals, period of performance, UEI, TIN, and business size certification to Mr. Michael Falzone, Contracting Officer, at Michael.falzone@nih.gov. The procurement carries NAICS code 622110 (General Medical and Surgical Hospitals) and PSC code R499 (Support—Professional: Other).
Notice text
Attachment: Notice of Intent to Sole Source
Files
| File | Type | Posted |
|---|---|---|
| Notice of Intent to Sole Source.pdf |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| iPSC Culture and Differentiation | Office of Logisitics and Acquisition Operations | No set-aside | |
| Reagents and consumables for Roche immunostainers | Office of Logisitics and Acquisition Operations | No set-aside | |
| Intent to Sole Source - Extended Support Renewal for Dell Unity 400 | NIH Clinical Center | No set-aside | |
| National Institute of Biomedical Imaging and Bioengineering (NIBIB) Innovation | Office of Logisitics and Acquisition Operations | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity